| Literature DB >> 34899014 |
Samir Ibrahim Arif1, Ahmed Mohammed Aldukhail2, Meshari Dhaifallah Albaqami3, Rodella Cabauatan Silvano4, Maher A Titi5,6, Bandar I Arif7, Yasser S Amer5,6,8,9, Hayfaa Wahabi10.
Abstract
BACKGROUND: Vaccination is considered the best way to prevent the spread of COVID-19 and to prevent the complications of the disease. Nevertheless, no awareness campaigns were conducted in Saudi Arabia until March 1, 2021, when the Vaxzevria, or ChAdOx1 nCoV-19 (AZD1222), vaccine became available.Entities:
Keywords: COVID-19; Cross-sectional study; Healthcare; Intention; Predictors; Saudi Arabia; Vaccine; Workers
Year: 2021 PMID: 34899014 PMCID: PMC8645262 DOI: 10.1016/j.sjbs.2021.11.058
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
Demographics statistics.
| N | (%) | ||
|---|---|---|---|
| Ever had a COVID19 vaccine | No | 61 | (11.53) |
| Yes | 468 | (88.47) | |
| Gender | Female - | 362 | (68.43) |
| Male - | 167 | (31.57) | |
| Monthly Income | 10001–15000 | 90 | (17.01) |
| 15001–20000 | 52 | (9.83) | |
| 5001–10000 | 248 | (46.88) | |
| less than 5000 | 104 | (19.66) | |
| More than 20,000 | 35 | (6.62) | |
| Marital Status | Married | 290 | (54.82) |
| Separated/ Divorced / | 13 | (2.46) | |
| Single | 226 | (42.72) | |
| Hours Worked Per Week | 20 | 68 | (12.85) |
| 45 | 267 | (50.47) | |
| 21–44 | 194 | (36.67) | |
| Presence of a Long-term physical health condition | No | 444 | (83.93) |
| Yes | 85 | (16.07) | |
| Presence of a Long-term mental health condition | No | 505 | (95.46) |
| Yes | 24 | (4.54) | |
| Current Profession | Administrator | 41 | (7.75) |
| Allied health professional | 23 | (4.35) | |
| EMS | 1 | (0.19) | |
| Nurse | 223 | (42.16) | |
| Other | 109 | (20.60) | |
| Pharmacist | 16 | (3.02) | |
| Physician | 88 | (16.64) | |
| Technician (e.g. lab CSSD radiology anesthesia tech, etc.) | 28 | (5.29) | |
| No of Years Worked in Health Care Field | >15 | 94 | (17.77) |
| 10-Jun | 140 | (26.47) | |
| 15-Nov | 106 | (20.04) | |
| 5-Jan | 189 | (35.73) | |
| Education Level | Bachelor | 342 | (64.65) |
| Board/fellowship | 21 | (3.97) | |
| Diploma | 96 | (18.15) | |
| Master PhD | 56 | (10.59) | |
| Other | 14 | (2.65) | |
| Nationality | Non-Saudi | 243 | (45.94) |
| Saudi | 286 | (54.06) | |
| Current Department | Critical Care Unit (ICU CCU. etc.) | 72 | (13.61) |
| Emergency Medicine | 14 | (2.65) | |
| Fever /Flu clinic | 2 | (0.38) | |
| General Ward | 75 | (14.18) | |
| Isolation areas | 8 | (1.51) | |
| Laboratory | 23 | (4.35) | |
| Operating Room | 35 | (6.62) | |
| Other | 218 | (41.21) | |
| Outpatient Clinics | 61 | (11.53) | |
| Radiology department | 21 | (3.97) | |
| Living Arrangement | Live alone | 85 | (16.07) |
| With others (including children) | 243 | (45.94) | |
| With others (not children) | 201 | (38.00) | |
| Smoking Status | Current smoker | 45 | (8.51) |
| Never smoked | 448 | (84.69) | |
| Past smoker | 36 | (6.81) | |
| Infection status | Infected | 95 | (18) |
| Non-infected | 511 | (82) | |
| Infection rate vs involvement in COVID-19 care | Infected and directly exposed | 35 | (6.61) |
| Infected not exposed | 60 | (11.34) | |
| Not infected but exposed | 130 | (24.57) | |
| Not infected not exposed | 300 | (56.7) | |
| Relative or friend who have died because of COVID | Yes | 248 | (46.8) |
| No | 281 | (53.2) | |
| Total | 529 | (100.0) | |
Chi Square Analysis between COVID-19 vaccine acceptance and socio demographic variables.
| N | % | Chi-Square Tests | |||||
|---|---|---|---|---|---|---|---|
| Value | df | P value | |||||
| Gender | Female - | 362 | (68.43) | Pearson Chi-Square | 21.016a | 4 | 0.0003 |
| Male - | 167 | (31.57) | Likelihood Ratio | 20.56218 | 4 | 0.0004 | |
| Monthly Income | 10001–15000 | 90 | (17.01) | Pearson Chi-Square | 28.559a | 16 | 0.0271 |
| 15001–20000 | 52 | (9.83) | Likelihood Ratio | 30.76866 | 16 | 0.0144 | |
| 5001–10000 | 248 | (46.88) | |||||
| less than 5000 | 104 | (19.66) | |||||
| More than 20,000 | 35 | (6.62) | |||||
| Marital Status | Married | 290 | (54.82) | Pearson Chi-Square | 16.641a | 8 | 0.0341 |
| Separated/ Divorced / | 13 | (2.46) | Likelihood Ratio | 17.69153 | 8 | 0.0237 | |
| Single | 226 | (42.72) | |||||
| Level of Education | Bachelor | 342 | (64.65) | Pearson Chi-Square | 37.885a | 16 | 0.0016 |
| Board/fellowship | 21 | (3.97) | Likelihood Ratio | 42.83933 | 16 | 0.0003 | |
| Diploma | 96 | (18.15) | |||||
| Master PhD | 56 | (10.59) | |||||
| Other | 14 | (2.65) | |||||
| Direct Involvement with COVID-19 Patients | Infected and directly exposed | 35 | (6.61) | Pearson Chi-Square | 5.735a | 4 | 0.2198 |
| Infected not exposed | 60 | (11.34) | Likelihood Ratio | 5.816113 | 4 | 0.2133 | |
| Not infected but exposed | 130 | (24.57) | |||||
| Not infected not exposed | 300 | (56.7) | |||||
| Have relative or Friend with or died of COVID-19 | Yes | 248 | (46.8) | Pearson Chi-Square | 7.393a | 4 | 0.1165 |
| No | 281 | (53.2) | Likelihood Ratio | 7.469274 | 4 | 0.1131 | |
Linear Logistic Regression of different variables.
| Variables in the Equation | ||||||
|---|---|---|---|---|---|---|
| B | S.E. | Wald | df | Sig. | Exp(B) | |
| Vaccine convenience is an important factor in vaccination decision-making | 0.39 | 0.14 | 7.62 | 1 | 0.006 | 0.675 |
| It is possible that I would take the vaccination if one of my family or friends has already taken it | 0.30 | 0.15 | 3.88 | 1 | 0.049 | 1.353 |
| The vaccine should be mandatory by the government Ministry of Health | −0.27 | 0.12 | 4.86 | 1 | 0.028 | 0.762 |
| Have your children been vaccinated based on the pediatric vaccination schedule? | 0.063 | 0.54 | 6.06 | 1 | 0.294 | 1.276 |
| Have you been vaccinated against influenza in the past season? | 0.260 | 0.76 | 2.28 | 1 | 0.473 | 1.554 |
| I have refused vaccination of a certain type of vaccine in the past When will you get COVID-19 vaccine | 0.500 | 0.73 | 3.73 | 1 | 0.652 | 2.823 |
| Taking the COVID-19 vaccine will protect me, my family, and the community from contracting the virus. | 0.177 | 0.99 | 8.94 | 1 | 0.831 | 1.118 |
| Getting vaccinated is the best way to avoid infection with Covid-19 disease compared to other preventive measures (washing hands, wearing a muzzle and social distancing | 0.1745 | 0.12 | 4.54 | 1 | 0.119 | 3.333 |
| Vaccination most of the community with the Covid-19 vaccine will eradicate the virus and make life return to normal. | 0.1268 | 0.41 | 5.63 | 1 | 0.318 | 2.660 |
| The vaccine should be mandatory by the employer (e.g., hospitals) | 3.981 | 0.64 | 1.23 | 1 | 0.587 | 4.910 |
| My acceptance of the vaccination depends on my doctor's recommendation. | 4.062 | 0.53 | 1.18 | 1 | 0.766 | 2.294 |
| My failure to take the Covid-19 vaccine depends on my concern about the side effects associated with the vaccine. | 3.294 | 0.66 | 5.33 | 1 | 0.941 | 2.473 |
| I will not take the new COVID-19 vaccine, as I think it is only propaganda or commercial profiteering. | 2.473 | 0.41 | 7.60 | 1 | 0.112 | 4.652 |
| I will not take the COVID-19 vaccine because I think it is not working well. | 0.752 | 0.52 | 8.10 | 1 | 0.099 | 2.831 |
| I will not take the COVID-19 vaccine because I prefer natural immunity | 0.731 | 0.31 | 8.87 | 1 | 0.073 | 3.237 |
| I think the benefits of the COVID-19 vaccines outweigh their harms or risks | 0.619 | 0.37 | 4.66 | 1 | 0.276 | 4.189 |
| Have you received the first dose or completed the COVID-19 vaccination (for any of the available vaccines) | 1.276 | 0.89 | 2.41 | 1 | 0.554 | 2.330 |
| I am confident our local healthcare services can handle the pandemic | 1.354 | 0.30 | 2.12 | 1 | 0.823 | 4.602 |
| I follow the national guidelines for COVID-19 issued by the Saudi Ministry of Health (SMoH) and the Saudi Center for Disease Prevention and Control (SCDC-Weqaya) | 2.623 | 0.91 | 7.99 | 1 | 0.118 | 2.104 |
| I follow the other international guidelines for COVID-19 (e.g., by World Health Organization) | 1.218 | 0.60 | 3.73 | 1 | 0.333 | 2.876 |
| I am satisfied with the preventive precautionary measures at my workplace | 3.433 | 0.78 | 1.76 | 1 | 0.660 | 3.668 |
| The covid-19 pandemic had a great impact on my daily life | 8.745 | 0.86 | 4.54 | 1 | 0.910 | 4.410 |
Multiple Linear regression.
Multiple Linear regression Model Summary.
| Model Summary | ||||
|---|---|---|---|---|
| Model | R | R Square | Adjusted R Square | Std. Error of the Estimate |
| 1 | .587a | 0.34 | 0.32 | 1.10 |
Multiple Linear regression (ANOVA test).
| ANOVA | |||||
|---|---|---|---|---|---|
| Sum of Squares | df | Mean Square | F | Sig. | |
| Regression | 325.33 | 19 | 17.12 | 14.07 | .000b |
| Residual | 619.44 | 509 | 1.22 | ||
| Total | 944.78 | 528 |
Multiple Linear regression (Regression Results).
| Unstandardized Coefficients | t | Sig. | ||
|---|---|---|---|---|
| B | Std. Error | |||
| (Constant) | 0.1342 | 0.1758 | 0.7633 | 0.4456 |
| Propaganda or commercial profiteering | −0.1768 | 0.0444 | 3.9817 | 0.0001 |
| Vaccine convenience | 0.1745 | 0.0429 | 4.0629 | 0.0001 |
| National guidelines for COVID-19 | 0.1268 | 0.0551 | 2.3001 | 0.0218 |